Skip to content

AmBeR UCD: can we measure ammonia in breath sample?

Assessment of a breath ammonia monitoring device for its potential to improve the management and care of patients with urea cycle disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN98291277
Enrollment
126
Registered
2017-11-29
Start date
2017-11-10
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Children, Primary sub-specialty: Inherited Metabolic Disorders

Interventions

There are two parts to this research project: Clinic Study and Home Study. Clinic Study: Once a participant has provided written consent and assent as appropriate, the participant is
this is similar to natural breathing and does not involve a forced exhale in older children. However, in younger children, it may require a larger than normal inhale and exhale, the same as taking a d

Sponsors

University Hospitals Bristol NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Clinic Study: Inclusion criteria for patients with Urea Cycle Disorder and other hyper-ammonaemic conditions 1. Aged = 5 years 2. Diagnosis of a UCD or other hyper-ammonaemic condition 3. Capable of providing a valid breath sample 4. Providing a blood sample as part of their clinical care Clinic Study: Inclusion criteria for control patients 1. Patients without a UCD or another hyper-ammonaemic condition attending for a routine inborn error of metabolism (IEM) hospital appointment and providing a blood sample as part of their clinical care. An additional 1-2ml whole blood is required for the measurement of blood ammonia. 2. Aged = 5 years 3. Capable of providing a valid breath sample Home Study: Inclusion criteria (patients with Urea Cycle Disorder or other hyper-ammonaemic conditions) 1. Aged = 5 years 2. Diagnosis of a UCD or other hyper-ammonaemic condition 3. Capable of providing valid breath samples 4. Family willing to help patient collect breath samples and record data

Exclusion criteria

Exclusion criteria: Children under five years of age.

Design outcomes

Primary

MeasureTime frame
Clinic Study: Breath ammonia is measured using an ammonia breath monitor (AmBeR) at one occasion. Home Study: Breath ammonia is measured using an ammonia breath monitor (AmBeR) daily for a 3 month period.

Secondary

MeasureTime frame
There are no secondary outcome measures.

Countries

England, United Kingdom

Contacts

Public ContactJulian Hamilton-Shield
J.P.H.Shield@bristol.ac.uk+44 (0)1173420159

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026